Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 09-2022 | 07-2022 | 06-2022 | 04-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,310 | -5,330 | N/A | -3,858 | N/A |
| Depreciation Amortization | 24 | 17 | 13 | 13 | 13 |
| Other Working Capital | 1,311 | 461 | -102 | -102 | -102 |
| Other Operating Activity | 2,026 | 1,333 | 691 | 691 | 691 |
| Operating Cash Flow | $-3,949 | $-3,519 | $602 | $-3,256 | $602 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | 0 | N/A | 0 |
| Investing Cash Flow | $-6 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 583 | N/A | 629 | N/A |
| Other Financing Activity | 543 | -2 | 0 | 0 | 0 |
| Financing Cash Flow | $543 | $581 | $N/A | $629 | $N/A |
| Exchange Rate Effect | -24 | 0 | N/A | 0 | N/A |
| Beginning Cash Position | 3,573 | 3,370 | N/A | 3,370 | N/A |
| End Cash Position | 137 | 386 | N/A | 743 | N/A |
| Net Cash Flow | $-3,436 | $-2,984 | $602 | $-2,627 | $602 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,949 | -3,519 | 602 | -3,256 | 602 |
| Free Cash Flow | -3,949 | -3,519 | 602 | -3,256 | 602 |